| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |